$1.47 Billion is the total value of Rhenman & Partners Asset Management AB's 94 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 17.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UNH | Buy | UNITED HEALTH GROUP INC | $50,055,000 | +19.1% | 125,000 | +10.6% | 3.40% | +15.9% |
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $49,161,000 | -10.2% | 525,000 | -11.8% | 3.34% | -12.6% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $43,531,000 | +20.3% | 215,897 | +28.2% | 2.96% | +17.1% |
| JAZZ | Sell | JAZZ PHARMACEUTICALS PLC | $39,081,000 | -4.9% | 220,000 | -12.0% | 2.65% | -7.4% |
| ANTM | ANTHEM INC | $36,271,000 | +6.4% | 95,000 | 0.0% | 2.46% | +3.5% | |
| ABBV | Sell | ABBVIE INC | $36,045,000 | -9.5% | 320,000 | -13.0% | 2.45% | -11.9% |
| TDOC | Buy | TELADOC HEALTH INC | $34,921,000 | +1.1% | 210,000 | +10.5% | 2.37% | -1.6% |
| MDT | Sell | MEDTRONIC PLC | $33,887,000 | -14.4% | 273,000 | -18.5% | 2.30% | -16.6% |
| CVS | Sell | CVS HEALTH CORP | $31,707,000 | -6.3% | 380,000 | -15.6% | 2.15% | -8.8% |
| BIIB | Buy | BIOGEN INC | $31,164,000 | +471.3% | 90,000 | +361.5% | 2.12% | +456.6% |
| CI | Buy | CIGNA CORP NEW | $30,938,000 | +16.3% | 130,500 | +18.6% | 2.10% | +13.3% |
| ABT | Sell | ABBOTT LABS | $28,983,000 | -12.1% | 250,000 | -9.1% | 1.97% | -14.4% |
| LLY | Sell | LILLY ELI & CO | $27,267,000 | -14.1% | 118,800 | -30.1% | 1.85% | -16.4% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $26,652,000 | +3.7% | 165,000 | +10.0% | 1.81% | +0.9% |
| NVCR | Sell | NOVOCURE LTD | $26,618,000 | +11.9% | 120,000 | -33.3% | 1.81% | +8.9% |
| TMO | Buy | THERMO FISHER SCIENTIFIC INC | $25,224,000 | +22.8% | 50,000 | +11.1% | 1.71% | +19.6% |
| XLRN | Buy | ACCELERON PHARMA INC | $25,098,000 | +15.7% | 200,000 | +25.0% | 1.70% | +12.6% |
| SGEN | Buy | SEAGEN INC | $24,933,000 | +124.4% | 157,925 | +97.4% | 1.69% | +118.3% |
| HUM | Sell | HUMANA INC | $24,350,000 | -15.8% | 55,000 | -20.3% | 1.65% | -18.0% |
| AXNX | Sell | AXONICS MODULATION TECHNOLOG | $24,096,000 | -1.9% | 380,000 | -7.3% | 1.64% | -4.4% |
| MRK | Buy | MERCK & CO. INC | $23,331,000 | +12.1% | 300,000 | +11.1% | 1.58% | +9.2% |
| VEEV | Buy | VEEVA SYS INC | $23,321,000 | +711.4% | 75,000 | +581.8% | 1.58% | +691.5% |
| ALNY | ALNYLAM PHARMACEUTICALS INC | $22,885,000 | +20.1% | 135,000 | 0.0% | 1.55% | +16.9% | |
| ZBH | Buy | ZIMMER BIOMET HOLDINGS INC | $22,515,000 | +8.2% | 140,000 | +7.7% | 1.53% | +5.3% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $22,235,000 | -14.1% | 520,000 | -22.4% | 1.51% | -16.4% |
| GH | Sell | GUARDANT HEALTH INC | $21,733,000 | -36.7% | 175,000 | -22.2% | 1.48% | -38.4% |
| ISRG | Sell | INTUITIVE SURGICAL INC | $20,692,000 | -3.4% | 22,500 | -22.4% | 1.40% | -6.0% |
| GILD | Sell | GILEAD SCIENCES INC | $20,658,000 | -8.7% | 300,000 | -14.3% | 1.40% | -11.1% |
| INOV | Buy | INOVALON HLDGS INC | $20,448,000 | +230.4% | 600,000 | +179.1% | 1.39% | +222.0% |
| ABMD | Sell | ABIOMED INC | $20,287,000 | -18.4% | 65,000 | -16.7% | 1.38% | -20.5% |
| ABC | Buy | AMERISOURCEBERGEN CORP | $19,807,000 | -0.1% | 173,000 | +3.0% | 1.34% | -2.8% |
| PFE | New | PFIZER INC | $19,580,000 | – | 500,000 | +100.0% | 1.33% | – |
| BHVN | BIOHAVEN PHARMACTL HLDG CO L | $19,457,000 | +42.0% | 200,419 | 0.0% | 1.32% | +38.3% | |
| EXAS | Sell | EXACT SCIENCES CORP | $19,268,000 | -16.5% | 155,000 | -11.4% | 1.31% | -18.7% |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $19,276,000 | +66.4% | 305,000 | +13.0% | 1.31% | +61.9% |
| CNC | Sell | CENTENE CORP DEL | $18,962,000 | -29.4% | 260,000 | -38.1% | 1.29% | -31.2% |
| COO | Sell | COOPER COS INC | $17,832,000 | -7.1% | 45,000 | -10.0% | 1.21% | -9.6% |
| ITCI | Sell | INTRA CELLULAR THERAPIES INC | $17,541,000 | +12.9% | 429,728 | -6.1% | 1.19% | +10.0% |
| NKTR | Sell | NEKTAR THERAPEUTICS | $16,302,000 | -37.6% | 950,000 | -27.3% | 1.11% | -39.3% |
| ACCD | Buy | ACCOLADE INC | $16,293,000 | +79.6% | 300,000 | +50.0% | 1.11% | +74.7% |
| PHR | Buy | PHREESIA INC | $15,938,000 | +409.9% | 260,000 | +333.3% | 1.08% | +396.3% |
| HCA | HCA HEALTHCARE INC | $15,506,000 | +9.8% | 75,000 | 0.0% | 1.05% | +6.9% | |
| MCK | Sell | MCKESSON CORP | $14,917,000 | -13.1% | 78,000 | -11.4% | 1.01% | -15.4% |
| MGNX | MACROGENICS INC | $14,643,000 | -15.7% | 545,160 | 0.0% | 0.99% | -17.9% | |
| REGN | Buy | REGENERON PHARMACEUTICALS | $13,964,000 | +47.6% | 25,000 | +25.0% | 0.95% | +43.6% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $13,350,000 | -1.8% | 160,000 | -11.1% | 0.91% | -4.4% |
| HCAT | Buy | HEALTH CATALYST INC | $13,322,000 | +147.7% | 240,000 | +108.7% | 0.90% | +141.1% |
| JNJ | Sell | JOHNSON & JOHNSON | $12,356,000 | -76.9% | 75,000 | -76.9% | 0.84% | -77.5% |
| RCM | Buy | R1 RCM INC | $12,232,000 | +147.8% | 550,000 | +175.0% | 0.83% | +141.3% |
| ESPR | Sell | ESPERION THERAPEUTICS INC NE | $12,103,000 | -27.1% | 572,267 | -3.4% | 0.82% | -29.0% |
| AERI | AERIE PHARMACEUTICALS INC | $12,008,000 | -10.4% | 750,000 | 0.0% | 0.82% | -12.8% | |
| XNCR | Buy | XENCOR INC | $11,727,000 | +15.9% | 340,000 | +44.7% | 0.80% | +12.7% |
| BDX | Sell | BECTON DICKINSON & CO | $11,673,000 | -43.5% | 48,000 | -43.5% | 0.79% | -45.0% |
| EW | EDWARDS LIFESCIENCES CORP | $11,393,000 | +23.8% | 110,000 | 0.0% | 0.77% | +20.6% | |
| ONEM | Buy | 1LIFE HEALTHCARE INC | $10,910,000 | +39.6% | 330,000 | +65.0% | 0.74% | +36.0% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $10,219,000 | -32.2% | 105,000 | -32.3% | 0.69% | -34.0% |
| SAVA | New | CASSAVA SCIENCES INC | $9,826,000 | – | 115,000 | +100.0% | 0.67% | – |
| SGMO | SANGAMO THERAPEUTICS INC | $9,157,000 | -4.5% | 765,000 | 0.0% | 0.62% | -6.9% | |
| BAX | Sell | BAXTER INTL INC | $8,855,000 | -44.7% | 110,000 | -42.1% | 0.60% | -46.2% |
| BMY | Sell | BRISTOL MYERS SQUIBB CO | $8,353,000 | -59.3% | 125,000 | -61.5% | 0.57% | -60.4% |
| IMGN | Buy | IMMUNOGEN INC | $8,032,000 | +80.3% | 1,218,850 | +121.6% | 0.54% | +75.2% |
| RVNC | Buy | REVANCE THERAPEUTICS INC | $8,003,000 | +30.2% | 270,000 | +22.7% | 0.54% | +26.6% |
| RDUS | RADIUS HEALTH INC | $7,843,000 | -12.6% | 430,000 | 0.0% | 0.53% | -14.9% | |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $7,806,000 | -16.4% | 300,000 | +1.7% | 0.53% | -18.6% |
| ALKS | Buy | ALKERMES PLC | $7,585,000 | +93.9% | 309,354 | +47.8% | 0.52% | +88.6% |
| EPIX | ESSA PHARMA INC | $7,428,000 | -1.7% | 260,000 | 0.0% | 0.50% | -4.4% | |
| DVAX | Sell | DYNAVAX TECHNOLOGIES CORP | $7,388,000 | -4.4% | 750,000 | -4.6% | 0.50% | -7.1% |
| GTHX | G1 THERAPEUTICS INC | $7,131,000 | -8.8% | 325,000 | 0.0% | 0.48% | -11.2% | |
| SILK | SILK ROAD MEDICAL INC | $6,988,000 | -5.5% | 146,000 | 0.0% | 0.47% | -8.1% | |
| MGTX | MEIRAGTX HLDGS PLC | $6,975,000 | +7.4% | 450,000 | 0.0% | 0.47% | +4.4% | |
| RIGL | RIGEL PHARMACEUTICALS INC | $6,597,000 | +26.9% | 1,520,000 | 0.0% | 0.45% | +23.8% | |
| STXS | STEREOTAXIS INC | $6,598,000 | +43.5% | 684,402 | 0.0% | 0.45% | +39.6% | |
| SWAV | Sell | SHOCKWAVE MEDICAL INC | $6,449,000 | -1.0% | 33,990 | -32.0% | 0.44% | -3.5% |
| PHAT | Buy | PHATHOM PHARMACEUTICALS INC | $6,303,000 | -4.1% | 186,210 | +6.4% | 0.43% | -6.6% |
| ZLAB | Sell | ZAI LAB LTDadr | $6,195,000 | +3.2% | 35,000 | -22.2% | 0.42% | +0.5% |
| MYOV | Buy | MYOVANT SCIENCES LTD | $5,693,000 | +22.9% | 250,000 | +11.1% | 0.39% | +19.5% |
| THC | New | TENET HEALTHCARE CORP | $5,694,000 | – | 85,000 | +100.0% | 0.39% | – |
| ANNX | Buy | ANNEXON INC | $5,628,000 | +12.3% | 250,000 | +38.9% | 0.38% | +9.5% |
| OSH | Sell | OAK STR HEALTH INC | $5,564,000 | -10.8% | 95,000 | -17.4% | 0.38% | -13.1% |
| FGEN | FIBROGEN INC | $5,326,000 | -23.3% | 200,000 | 0.0% | 0.36% | -25.2% | |
| VRAY | VIEWRAY INCadr | $5,115,000 | +51.7% | 775,000 | 0.0% | 0.35% | +47.7% | |
| PGNY | New | PROGYNY INC | $4,720,000 | – | 80,000 | +100.0% | 0.32% | – |
| SAGE | New | SAGE THERAPEUTICS INC | $4,261,000 | – | 75,000 | +100.0% | 0.29% | – |
| ARNA | ARENA PHARMACEUTICALS INC | $4,092,000 | -1.7% | 60,000 | 0.0% | 0.28% | -4.1% | |
| IMCR | New | IMMUNOCORE HLDGS PLCads | $3,515,000 | – | 90,000 | +100.0% | 0.24% | – |
| INNV | New | INNOVAGE HLDG CORP | $3,197,000 | – | 150,000 | +100.0% | 0.22% | – |
| SBTX | New | SILVERBACK THERAPEUTICS INC | $3,089,000 | – | 100,000 | +100.0% | 0.21% | – |
| IONS | IONIS PHARMACEUTICALS INC | $2,992,000 | -11.3% | 75,000 | 0.0% | 0.20% | -13.6% | |
| GKOS | GLAUKOS CORP | $2,969,000 | +1.1% | 35,000 | 0.0% | 0.20% | -1.5% | |
| HRMY | New | HARMONY BIOSCIENCES HLDGS IN | $2,823,000 | – | 100,000 | +100.0% | 0.19% | – |
| DCPH | DECIPHERA PHARMACEUTICALS INC | $2,197,000 | -18.3% | 60,000 | 0.0% | 0.15% | -20.7% | |
| EPZM | EPIZYME INC | $2,202,000 | -4.6% | 265,000 | 0.0% | 0.15% | -7.5% | |
| PIRS | PIERIS PHARMACEUTICALS INC | $1,149,000 | +49.0% | 300,000 | 0.0% | 0.08% | +44.4% | |
| LIVN | Sell | LIVANOVA PLC | $841,000 | -92.6% | 10,000 | -93.5% | 0.06% | -92.8% |
| NXGN | Exit | NEXTGEN HEALTHCARE INC | $0 | – | -150,000 | -100.0% | -0.19% | – |
| GDRX | Exit | GOODRX HLDGS INC | $0 | – | -75,000 | -100.0% | -0.20% | – |
| AMWL | Exit | AMERICAN WELL CORPcl a | $0 | – | -194,165 | -100.0% | -0.24% | – |
| NUAN | Exit | NUANCE COMMUNICATIONS INC | $0 | – | -90,000 | -100.0% | -0.27% | – |
| RPRX | Exit | ROYALTY PHARMA PLC | $0 | – | -130,000 | -100.0% | -0.40% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -40,000 | -100.0% | -0.43% | – |
| ADVM | Exit | ADVERUM BIOTECHNOLOGIES INC | $0 | – | -650,000 | -100.0% | -0.45% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITEDHEALTH GROUP INC | 40 | Q3 2023 | 4.0% |
| BIOMARIN PHARMACEUTICAL INC | 40 | Q3 2023 | 5.0% |
| ALKERMES PLC | 40 | Q3 2023 | 3.3% |
| LILLY ELI & CO | 39 | Q3 2023 | 5.8% |
| CVS HEALTH CORP | 39 | Q3 2023 | 3.5% |
| INTRA-CELLULAR THERAPIES INC | 39 | Q3 2023 | 2.4% |
| EDWARDS LIFESCIENCES CORP | 39 | Q3 2023 | 1.7% |
| VERTEX PHARMACEUTICALS INC | 38 | Q3 2023 | 4.3% |
| REVANCE THERAPEUTICS INC | 38 | Q3 2023 | 0.9% |
| ABBVIE INC | 37 | Q3 2023 | 4.4% |
View Rhenman & Partners Asset Management AB's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR/A | 2023-11-13 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Rhenman & Partners Asset Management AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.